Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
24 juil. 2024 08h30 HE
|
Sonnet BioTherapeutics Holdings, Inc.
Data indicates that SON-080 was well-tolerated at both doses, with no evidence of a pro-inflammatory cytokine responsePain and quality of life survey results suggest the potential for rapid...
Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
20 juin 2024 08h30 HE
|
Sonnet BioTherapeutics Holdings, Inc.
PRINCETON, N.J., June 20, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) (the “Company” or “Sonnet”), a clinical-stage company developing targeted immunotherapeutic...
Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
28 mai 2024 08h00 HE
|
Sonnet BioTherapeutics Holdings, Inc.
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted biologic...
Sonnet BioTherapeutics Holdings Announces Merger Closing
01 avr. 2020 17h53 HE
|
Sonnet BioTherapeutics Holdings, Inc.
- Trading under “SONN” on the Nasdaq Capital Market to begin April 2, 2020- Closed $19 million financing PRINCEON, N.J., April 01, 2020 (GLOBE NEWSWIRE) -- Sonnet BioTherapuetics Holdings, Inc.,...
Chanticleer Holdings Announces 1:1 Distribution Ratio for Spin-Off and Provides Corporate Update
24 mars 2020 17h38 HE
|
Chanticleer Holdings, Inc.
CHARLOTTE, N.C., March 24, 2020 (GLOBE NEWSWIRE) -- Chanticleer Holdings, Inc. (Nasdaq: BURG) (the “Company” or “Chanticleer”), owner, operator and franchisor of multiple nationally-recognized...
Chanticleer Holdings Announces Merger S-4 Effective by SEC
14 févr. 2020 12h28 HE
|
Chanticleer Holdings, Inc.
CHARLOTTE, N.C., Feb. 14, 2020 (GLOBE NEWSWIRE) -- Chanticleer Holdings, Inc. (NASDAQ:BURG) (“Chanticleer” or the “Company”), owner, operator, and franchisor of multiple nationally recognized...